Literature DB >> 16024632

Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

Bodo Brueckner1, Regine Garcia Boy, Pawel Siedlecki, Tanja Musch, H Christian Kliem, Piotr Zielenkiewicz, Sandor Suhai, Manfred Wiessler, Frank Lyko.   

Abstract

DNA methylation regulates gene expression in normal and malignant cells. The possibility to reactivate epigenetically silenced genes has generated considerable interest in the development of DNA methyltransferase inhibitors. Here, we provide a detailed characterization of RG108, a novel small molecule that effectively blocked DNA methyltransferases in vitro and did not cause covalent enzyme trapping in human cell lines. Incubation of cells with low micromolar concentrations of the compound resulted in significant demethylation of genomic DNA without any detectable toxicity. Intriguingly, RG108 caused demethylation and reactivation of tumor suppressor genes, but it did not affect the methylation of centromeric satellite sequences. These results establish RG108 as a DNA methyltransferase inhibitor with fundamentally novel characteristics that will be particularly useful for the experimental modulation of epigenetic gene regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024632     DOI: 10.1158/0008-5472.CAN-04-2957

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  157 in total

Review 1.  DNA methylation and microRNAs in cancer.

Authors:  Xiang-Quan Li; Yuan-Yuan Guo; Wei De
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.

Authors:  Sirano Dhe-Paganon; Farisa Syeda; Lawrence Park
Journal:  Int J Biochem Mol Biol       Date:  2011-01-30

Review 3.  Unravelling the genomic targets of small molecules using high-throughput sequencing.

Authors:  Raphaël Rodriguez; Kyle M Miller
Journal:  Nat Rev Genet       Date:  2014-10-14       Impact factor: 53.242

4.  Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.

Authors:  Sonam Sinha; Samriddhi Shukla; Sajid Khan; Trygve O Tollefsbol; Syed M Meeran
Journal:  Mol Cell Endocrinol       Date:  2015-02-25       Impact factor: 4.102

5.  DNA methylation in the medial prefrontal cortex regulates alcohol-induced behavior and plasticity.

Authors:  Estelle Barbier; Jenica D Tapocik; Nathan Juergens; Caleb Pitcairn; Abbey Borich; Jesse R Schank; Hui Sun; Kornel Schuebel; Zhifeng Zhou; Qiaoping Yuan; Leandro F Vendruscolo; David Goldman; Markus Heilig
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 6.  DNA methylation: its role in cancer development and therapy.

Authors:  Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
Journal:  Curr Probl Cancer       Date:  2008 Sep-Oct       Impact factor: 3.187

7.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

Review 8.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

9.  In Vitro and In Vivo Enzyme Activity Screening via RNA-Based Fluorescent Biosensors for S-Adenosyl-l-homocysteine (SAH).

Authors:  Yichi Su; Scott F Hickey; Samantha G L Keyser; Ming C Hammond
Journal:  J Am Chem Soc       Date:  2016-05-27       Impact factor: 15.419

10.  Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway.

Authors:  Xiang Li; Erchang Shang; Qiang Dong; Yingfeng Li; Jing Zhang; Shaohua Xu; Zuodong Zhao; Wei Shao; Cong Lv; Yong Zheng; Hailin Wang; Xiaoguang Lei; Bing Zhu; Zhuqiang Zhang
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.